Yuan Zhi
Stock Analyst at B. Riley Securities
(2.87)
# 1,573
Out of 5,126 analysts
32
Total ratings
41.94%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $4.97 | +221.93% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $69.24 | +25.65% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $12.51 | +11.91% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $4.71 | +133.55% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $24.07 | -8.60% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $2.61 | +129.89% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.10 | -9.09% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $2.94 | +512.24% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $8.72 | +72.02% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.68 | +338.02% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $28.78 | +174.50% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.15 | +1,291.30% | 4 | Dec 11, 2023 |
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $4.97
Upside: +221.93%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $69.24
Upside: +25.65%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $12.51
Upside: +11.91%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $4.71
Upside: +133.55%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $24.07
Upside: -8.60%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $2.61
Upside: +129.89%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.10
Upside: -9.09%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $2.94
Upside: +512.24%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $8.72
Upside: +72.02%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.68
Upside: +338.02%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $28.78
Upside: +174.50%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.15
Upside: +1,291.30%